A real-world study on the effectiveness of elbasvir/grazoprevir in the treatment of genotype 1 chronic hepatitis C

导出

摘要 Objective To evaluate the efficacy and safety of elbasvir/grazoprevir(EBR/GZR)in patients with genotype 1 chronic hepatitis C in the real-world.Methods This was an open-label,single-center,retrospective realworld study.A total of 103 genotype 1 chronic hepatitis C patients who were treated with EBR/GZR in Henan Provincial People’s Hospital from May 2018 to October 2019 were enrolled.

作者 LI Kuan 李宽(Dept Infect Dis,Henan Prov People’s Hosp,Zhengzhou 450003)

机构地区 Dept Infect Dis

出处《China Medical Abstracts(Internal Medicine)》 2021年第2期109-109,共1页 中国医学文摘（内科学分册（英文版）

关键词 HEPATITIS PATIENTS CHRONIC

分类号 R512.63 [医药卫生—内科学]

引文网络
相关文献

1Wei Wei,Pei-En Jian,Shao-Hua Li,Zhi-Xing Guo,Yong-Fa Zhang,Yi-Hong Ling,Xiao-Jun Lin,Li Xu,Ming Shi,Lie Zheng,Min-Shan Chen,Rong-Ping Guo.Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety[J].Cancer Communications,2018,38(1):655-666. 被引量：82
2Qiuyan Chen,Linquan Tang,Na Liu,Feng Han,Ling Guo,Shanshan Guo,Jianwei Wang,Huai Liu,Yanfang Ye,Lu Zhang,Liting Liu,Pan Wang,Yingqin Li,Qingmei He,Xiaoqun Yang,Qingnan Tang,Yang Li,YuJing Liang,XueSong Sun,Chuanmiao Xie,Yunxian Mo,Ying Guo,Rui Sun,Haoyuan Mo,Kajia Cao,Xiang Guo,Musheng Zeng,Haiqiang Mai,Jun Ma.Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study[J].Cancer Communications,2018,38(1):701-713. 被引量：8
3Ruoxi Hong,Wen Xia,Liye Wang,Kaping Lee,Qianyi Lu,Kuikui Jiang,Shengfeng Li,Jinquan Yu,Jin Wei,Weijia Tang,Danyang Zhou,Xin An,Jiajia Huang,Cong Xue,Xiwen Bi,Yanxia Shi,Zhongyu Yuan,Fei Xu,Shusen Wang.Safety,tolerability,and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer:An open-label,dose-escalation,phase I study[J].Cancer Communications,2021,41(2):171-182. 被引量：2
4Yan Qin,Yuqin Song,Zhixiang Shen,Xin Du,Wei Ji,Wanling Hsu,Jun Zhu,Yuankai Shi.Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial[J].Cancer Communications,2018,38(1):335-343. 被引量：4
5Jung Hoon Kim,Sang-Cheol Lee,Sung Yong Oh,Seo-Young Song,Namsu Lee,Eun Mi Nam,Soonil Lee,In Gyu Hwang,Hyo Rak Lee,Kyu Taek Lee,Sang-Byung Bae,Han Jo Kim,Joung Soon Jang,Do Hyoung Lim,Hyun Woo Lee,Seok Yun Kang,Jung Hun Kang.Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study[J].Cancer Communications,2018,38(1):344-351. 被引量：4

China Medical Abstracts(Internal Medicine)

2021年第2期

浏览历史

内容加载中请稍等...

A real-world study on the effectiveness of elbasvir/grazoprevir in the treatment of genotype 1 chronic hepatitis C

相关作者

相关机构

相关主题

浏览历史